CCO Treatment Updates

Answering the Questions: Practical Management Strategies to Address Cardiovascular Risk in HIV

Questions And Answers

Review the answers to Clinical Care Options member questions on the management of cardiovascular risk in HIV posted by our expert faculty. If you do not find what you are looking for, you can submit your own question.

 


Answering the Questions: Practical Management Strategies to Address Cardiovascular Risk in HIV

Module 1 of 2

Faculty:

Sally Hodder, MD headshotPaul E. Sax, MD headshotPablo Tebas, MD headshot
  • Sally Hodder, MD
  • Paul E. Sax, MD
  • Pablo Tebas, MD

CME CREDIT INFORMATION

Release Date: 03/11/08

Expiration Date: 03/10/09


Physicians: maximum of 1.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Sally Hodder, MD; Paul E. Sax, MD; and Pablo Tebas, MD, provide practical answers to frequently asked questions about diagnosing and managing cardiovascular risks in HIV-infected patients.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe practical strategies to prevent or minimize cardiovascular risk factors in HIV-infected patients
  • Summarize monitoring strategies for cardiovascular risk factors, including appropriate definitions, goals, and targets, in the context of HIV infection
  • Discuss approaches to the management of lipid changes and other cardiovascular risk factors in HIV-infected patients

Faculty Responses to Readers’ Questions: Practical Management Strategies to Address Cardiovascular Risk in HIV (coming soon)

Module 2 of 2

Faculty:

Sally Hodder, MD headshotPaul E. Sax, MD headshotPablo Tebas, MD headshot
  • Sally Hodder, MD
  • Paul E. Sax, MD
  • Pablo Tebas, MD

CME CREDIT INFORMATION

Release Date: --

Expiration Date: --


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Sally Hodder, MD, Paul E. Sax, MD, and Pablo Tebas, MD, offer practical responses to readers’ questions about managing cardiovascular risks in HIV-infected patients.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the role of novel markers and imaging techniques in managing cardiovascular risks in HIV-infected patients
  • Discuss the impact of specific antiretroviral agents on cardiovascular risks in HIV-infected patients
  • Discuss approaches to the management of lipid changes and other cardiovascular risk factors in HIV-infected patients

CCO Slideset

Answering the Questions: Practical Management Strategies for Cardiovascular Risk in HIV


Pablo Tebas, MD reviews the key data pertaining to frequently asked questions about diagnosing and managing cardiovascular risks in HIV-infected patients.


Format: Microsoft PowerPoint (.ppt) | File size: 1,358 KB
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.

Have a Question About CVD Risk Management?”

Submit your question to our expert faculty

   
Copy me on this submission.